September 19th, 2024 (Shanghai) — We are glad to announce that Nan Zhang, the Founder & Chief Executive Officer of NGB Innovation, will be presenting at the ACCESS CHINA Partnering Forum – Autumn Virtual Showcase during September 24th to 25th, and 27th, 2024. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.
About NGB Innovation
NGB Innovations is a human factors-oriented technology company specializing in hardware design and product manufacturing. Founded in 2023, the company is dedicated to creating innovative solutions that improve biotechnology practices across medical, agricultural, and space industries. NGB Innovations’ products are known for their meticulous attention to detail, precision, novelty, and quality. The company was honored as a finalist for the AUS SPACE 24 Start-up of the Year and was selected to present at the ARCS Start-up Session in Sydney in 2024.
The company’s first MVP stage product line, NG-C, is a cutting-edge device that combines cell lysing and gene cutting into one process, significantly reducing the overall working time from hours to just 5-10 minutes. NG-C is unique in that it operates without harsh chemicals, enzymes, or detergents, which have traditionally posed challenges in biotechnology. This innovation not only minimizes these issues but also provides a new method for extracting genes and proteins with food-grade safety on a large scale. NG-C’s development involved extensive testing, with over 100 tests conducted at the proof-of-concept stage and more than 20 tests completed on the MVP product, all demonstrating stable performance. NGB Innovations plans to initiate its first novel biomarker finding test once funding is secured.
About the speaker
Nan Zhang is a distinguished bioengineer with extensive experience in product design and commercialization. With a deep understanding of the biotechnology industry’s need for precision and accuracy, Nan founded NGB Innovations in 2023 in Sydney. Recognizing that current device and equipment development often prioritizes automation and AI over fundamental performance improvements, Nan established NGB Innovations to develop novel hardware that enhances the systematic and cost-efficient practice of biotechnology. Nan’s expertise spans signaling analysis for drug development, biomarker discovery, protein analysis, and addressing the high failure rates in clinical trials, which contribute to the lengthy and costly process of drug commercialization.
About ACCESS CHINA Partnering Forum
ACCESS CHINA Partnering Forum – Autumn Virtual Showcase is scheduled to be held on September 24th to 25th, and 27th, 2024, via Zoom webinar. This event helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, audience can have access to innovative pharma and healthcare products from worldwide.
Conference Name: ACCESS CHINA Partnering Forum
Date & Time: Sep 24 – 25 (live), and 27 (VoD) 2024, China time
Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception
Scale: Expected 500+ participants Online; 100 company roadshows
Participants: Pharma/Biotech senior management and BDs
View more information at https://biotochina.org/
REGISTER
To Register for ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
BioToChina.org 